Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas
Clinical trial NCT01276613 · TERMINATED
Trial details
- NCT number
- NCT01276613
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2019-04-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.